Nina Abide | FetalFirst Featured in Forbes France: How AI Is Redefining Prenatal Diagnosis
Forbes France spotlights FetalFirst and founder Nina Abide in a televised feature exploring how AI combines medical precision, empathy, and accessibility to transform prenatal diagnosis.
Nina Abide: From Personal Loss to FetalFirst – Full Founder Interview
Hear directly from FetalFirst Founder Nina Abide about her personal journey from patient to healthcare innovator, the heartbreaking experience that sparked FetalFirst, and how AI is transforming prenatal care globally. Full 59-minute interview with East Talks Business.
FetalFirst Submits Ethics for First Cross-Border EHDS Pathfinder Pilot in Fetal Anomaly Detection
FetalFirst announces submission of research ethics for a first-of-its-kind cross-border EHDS Pathfinder pilot in fetal anomaly detection using AI. The pilot begins at Tartu University Hospital in Estonia with plans to expand into Finland, demonstrating how advanced healthcare AI can scale ethically and reproducibly across European borders while maintaining patient privacy and data sovereignty.
Ruth Wilde Joins FetalFirst Advisory Board as Advisor for Family Support & Counselling
Leading Fertility Counsellor Ruth Wilde Joins FetalFirst Advisory Board
FetalFirst Registers Clinical Trial to Validate AI-Based Neonatal Risk Prediction
FetalFirst’s clinical trial “AI-Powered Neonatal Risk Assessment for Improved Perinatal Outcomes” is now officially registered on ClinicalTrials.gov (NCT07064356), marking a major milestone in our mission to deliver AI-driven diagnostics and support for high-risk pregnancies.
FetalFirst Joins NVIDIA Inception to Advance GPU-Powered Prenatal Diagnostics
FetalFirst has been accepted into NVIDIA Inception, marking a major milestone in our mission to transform fetal medicine. This strategic step gives us access to cutting-edge AI development resources, helping us scale our prenatal diagnostic platform globally.
World-Leading Genomics Expert Prof. Gudrun Moore Joins FetalFirst as Chief Scientific Advisor
World-leading genomics pioneer Prof. Gudrun Moore joins FetalFirst as Chief Scientific Advisor, bringing over 30 years’ experience to advance AI-powered fetal diagnostics, ethical genomics, and global family support through access to the Baby Bio Bank and quantum-accelerated technology.
FetalFirst Achieves NHS Research Ethics Committee Approval for Breakthrough AI Neonatal Risk Assessment Platform
FetalFirst receives full NHS research ethics approval to clinically validate its AI-powered neonatal risk assessment platform, marking a major regulatory milestone and positioning the company for rapid scale in the UK’s high-growth health tech sector.